EP2867671
METHODS FOR DETERMINING DRUG EFFICACY USING CEREBLON-ASSOCIATED PROTEINS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
28.6.2013EP published:
24.10.2018EP application number:
13736723.1
EPO information:
European Patent Register
Max expiry date:
27.6.2033
Title:
METHODS FOR DETERMINING DRUG EFFICACY USING CEREBLON-ASSOCIATED PROTEINS
Timeline
Today
28.6.2013EP application
24.10.2018EP Publication
Owner
Name:
Celgene CorporationAddress:
86 Morris Avenue, 07901, Summit, NJ, US
Inventor
Name:
SCHAFER, Peter, H.Address:
Belle Mead, NJ, US
Name:
CHOPRA, RajeshAddress:
Sutton, Surrey SM2 6NE, GB
Name:
CORRAL, LauraAddress:
La Jolla, CA, US
Name:
WANG, Maria, YinglinAddress:
San Diego, CA, US
Name:
JACKSON, PilgrimAddress:
San Diego, CA, US
Name:
LOPEZ-GIRONA, AntoniaAddress:
San Diego, CA, US
Priority
Number:
201261666703 PDate:
29.6.2012Country:
US
Number:
201261696752 PDate:
4.9.2012Country:
US
Classification
Categories:
G01N 33/50, G01N 33/574